Wednesday, July 6, 2011
amaurosis fugax
Amaurosis fugax (Latin fugax meaning fleeting, Greek amaurosis meaning darkening, dark, or obscure) is a transient monocular visual loss.
The experience of amaurosis fugax is classically described as a transient monocular vision loss that appears as a "curtain coming down vertically into the field of vision in one eye;" however, this altitudinal visual loss is relatively uncommon. In one study, only 23.8 percent of patients with transient monocular vision loss experienced the classic "curtain" or "shade" descending over their vision.[43]
Other descriptions of this experience include a monocular blindness, dimming, fogging, or blurring.[44] Total or sectorial vision loss typically lasts only a few seconds, but may last minutes or even hours. Duration depends on the etiology of the vision loss. Obscured vision due to papilledema may last only seconds, while a severely atherosclerotic carotid artery may be associated with a duration of one to ten minutes.[45] Certainly, additional symptoms may be present with the amaurosis fugax, and those findings will depend on the etiology of the transient monocular vision loss.
MANY CAUSES OF AMAUROSIS FUGAX
The experience of amaurosis fugax is classically described as a transient monocular vision loss that appears as a "curtain coming down vertically into the field of vision in one eye;" however, this altitudinal visual loss is relatively uncommon. In one study, only 23.8 percent of patients with transient monocular vision loss experienced the classic "curtain" or "shade" descending over their vision.[43]
Other descriptions of this experience include a monocular blindness, dimming, fogging, or blurring.[44] Total or sectorial vision loss typically lasts only a few seconds, but may last minutes or even hours. Duration depends on the etiology of the vision loss. Obscured vision due to papilledema may last only seconds, while a severely atherosclerotic carotid artery may be associated with a duration of one to ten minutes.[45] Certainly, additional symptoms may be present with the amaurosis fugax, and those findings will depend on the etiology of the transient monocular vision loss.
MANY CAUSES OF AMAUROSIS FUGAX
Tuesday, June 28, 2011
Resuscutation Sequence: Unwitnessed VFib Arrest
1. 2 minutes of CPR (prime the pump)
2. Shock (120-200 J biphasic defibrillator)
3. RESUME CHEST COMPRESSIONS immediately following shock (to eliminate delays)
4. Check pulse (10 seconds during second round of chest compressions)
5. If no pulse: Shock 200 J
6. RESUME CHEST COMPRESSIONS immediately following shock
2. Shock (120-200 J biphasic defibrillator)
3. RESUME CHEST COMPRESSIONS immediately following shock (to eliminate delays)
4. Check pulse (10 seconds during second round of chest compressions)
5. If no pulse: Shock 200 J
6. RESUME CHEST COMPRESSIONS immediately following shock
Friday, June 24, 2011
Local Anesthesia Toxicity (Lidocaine)
Local Anesthetic Agents Used Commonly for Infiltrative Injection
| Agent | Duration of Action | Maximum Dosage Guidelines (Total Cumulative Infiltrative Injection Dose per Procedure*) |
| Amides | ||
| Lidocaine (Xylocaine) | Medium (30-60 min) | Without epinephrine: 4.5 mg/kg; not to exceed 300 mg |
| Lidocaine with epinephrine | Long (120-360 min) | With epinephrine: 7 mg/kg |
| Bupivacaine (Marcaine) | Long (120-240 min) | Without epinephrine: 2.5 mg/kg; not to exceed 175 mg total dose |
| Bupivacaine with epinephrine | Long (180-420 min) | With epinephrine: Not to exceed 225 mg total dose |
| Bottom line Lidocaine 1% => 10mg per ml = Don't give more then 30 mls | ||
Thursday, June 23, 2011
Pediatic Resuscitation: SVT
Stable SVT
Vagal maneuvers:
Verapamil should not be used as blocking agent for in infants...Bradycardia and Hypotension
________________________________________
Unstable SVT:
Cardioversion:
Vagal maneuvers:
- Ice to face
- Blow through straw
- Initial: 0.1 mg/kg (max 6 mg)
- Susequant: 0.2 mg/kg (max 12 mg)
- Amiodarone: 5 mg/kg (over 20-60 min)
- Procainamide: 15 mg/kg (over 30-60 min)
Verapamil should not be used as blocking agent for in infants...Bradycardia and Hypotension
________________________________________
Unstable SVT:
Cardioversion:
- First dose: 0.5 - 1 J/kg
- Second dose: 2J/Kg
Monday, June 20, 2011
Subscribe to:
Posts (Atom)









